Found 405 matching trials
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
PHASE1The purpose of this study is to find the number of natural killer (NK) cell...
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
PHASE1This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Location
Institute of Hematology & Blood Diseases Hospital
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation
PHASE1The investigators propose a nonrandomized, Phase I study to assess the safe...
Location
Hammersmith Hospital
Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer
PHASE1The aim of this study is the safety and efficacy of cryosurgery plus NK imm...
Location
Cancer Institute in Fuda cancer hospital
GKL-006Allo Injection in Patients With Advanced Solid Tumors
PHASE1This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinet...
Location
Cancer Hospital Chinese Academy of Medical Sciences
CIML NK Cell in Head & Neck Cancer
PHASE1This research study is evaluating the safety and efficacy of a combination ...
Location
Dana Farber Cancer Institute
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
PHASE1This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Location
Peking University Shenzhen Hospital
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
PHASE1This is a Phase 1 open-label, study designed to characterize the safety, to...
Location
Washington University School of Medicine
Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD
PHASE1This is a single arm, open-label, multi-center, pilot studies (Investigator...
Location
First Affiliated Hospital of Fujian Medical University
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
PHASE1This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Location
Nkarta Investigational Site